Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macaca | 1 | 2023 | 62 | 0.810 |
Why?
|
| Face | 1 | 2023 | 189 | 0.730 |
Why?
|
| Facial Recognition | 1 | 2021 | 5 | 0.710 |
Why?
|
| Ketamine | 4 | 2023 | 226 | 0.710 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 3 | 2023 | 128 | 0.460 |
Why?
|
| Anesthetics, Dissociative | 1 | 2013 | 18 | 0.400 |
Why?
|
| Faculty | 1 | 2013 | 104 | 0.370 |
Why?
|
| Electroconvulsive Therapy | 2 | 2023 | 82 | 0.330 |
Why?
|
| Blood Donors | 2 | 2020 | 61 | 0.320 |
Why?
|
| Cognition | 3 | 2018 | 814 | 0.320 |
Why?
|
| Brain Injuries | 1 | 2013 | 715 | 0.270 |
Why?
|
| Physicians | 1 | 2013 | 635 | 0.250 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1161 | 0.230 |
Why?
|
| Sialyltransferases | 1 | 2024 | 7 | 0.230 |
Why?
|
| Oligosaccharides | 1 | 2024 | 77 | 0.210 |
Why?
|
| Antidepressive Agents | 2 | 2023 | 327 | 0.200 |
Why?
|
| Photic Stimulation | 1 | 2023 | 235 | 0.190 |
Why?
|
| Hepatitis B, Chronic | 1 | 2022 | 85 | 0.180 |
Why?
|
| Milk, Human | 1 | 2024 | 310 | 0.180 |
Why?
|
| Brain | 3 | 2023 | 3200 | 0.180 |
Why?
|
| Hepatitis B | 1 | 2022 | 171 | 0.170 |
Why?
|
| White Matter | 1 | 2023 | 211 | 0.170 |
Why?
|
| Primates | 1 | 2021 | 85 | 0.170 |
Why?
|
| Drug Resistance, Viral | 1 | 2020 | 50 | 0.170 |
Why?
|
| Luminescent Measurements | 1 | 2019 | 60 | 0.160 |
Why?
|
| Treponema pallidum | 1 | 2019 | 50 | 0.160 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 236 | 0.150 |
Why?
|
| Syphilis | 1 | 2019 | 98 | 0.150 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 1831 | 0.150 |
Why?
|
| Hepacivirus | 1 | 2020 | 272 | 0.140 |
Why?
|
| Computer Simulation | 1 | 2021 | 699 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 830 | 0.140 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 406 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 3853 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2020 | 388 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2020 | 822 | 0.110 |
Why?
|
| Bone Transplantation | 1 | 2014 | 50 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 87 | 0.100 |
Why?
|
| Anesthetics, Intravenous | 1 | 2013 | 47 | 0.100 |
Why?
|
| Anesthetics, Inhalation | 1 | 2013 | 46 | 0.100 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2013 | 42 | 0.100 |
Why?
|
| Osteogenesis | 1 | 2014 | 163 | 0.100 |
Why?
|
| Spinal Fusion | 1 | 2014 | 114 | 0.100 |
Why?
|
| Sleep Stages | 1 | 2013 | 34 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 42 | 0.100 |
Why?
|
| Arousal | 1 | 2013 | 81 | 0.100 |
Why?
|
| Verbal Learning | 1 | 2013 | 71 | 0.100 |
Why?
|
| Sleep Deprivation | 1 | 2013 | 45 | 0.100 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 989 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 573 | 0.090 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 182 | 0.090 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 142 | 0.090 |
Why?
|
| Impulsive Behavior | 1 | 2013 | 159 | 0.090 |
Why?
|
| Animals | 3 | 2023 | 34996 | 0.090 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2012 | 38 | 0.090 |
Why?
|
| Attention | 1 | 2013 | 200 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 133 | 0.090 |
Why?
|
| Methamphetamine | 1 | 2012 | 50 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2012 | 68 | 0.090 |
Why?
|
| Central Nervous System Stimulants | 1 | 2012 | 128 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1009 | 0.090 |
Why?
|
| Mothers | 2 | 2024 | 374 | 0.090 |
Why?
|
| Humans | 16 | 2024 | 132373 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 359 | 0.080 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 274 | 0.080 |
Why?
|
| China | 2 | 2020 | 290 | 0.080 |
Why?
|
| Sleep Wake Disorders | 1 | 2012 | 196 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2013 | 1230 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 697 | 0.070 |
Why?
|
| Female | 8 | 2024 | 70809 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2494 | 0.060 |
Why?
|
| Adult | 5 | 2024 | 31624 | 0.060 |
Why?
|
| Fucosyltransferases | 1 | 2024 | 30 | 0.060 |
Why?
|
| Male | 7 | 2024 | 65072 | 0.060 |
Why?
|
| Lactose | 1 | 2024 | 55 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2024 | 94 | 0.050 |
Why?
|
| Respiratory Sounds | 1 | 2024 | 72 | 0.050 |
Why?
|
| Gene-Environment Interaction | 1 | 2024 | 130 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1649 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 28895 | 0.050 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2023 | 20 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2023 | 54 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 60 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2023 | 49 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2023 | 64 | 0.050 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2022 | 54 | 0.050 |
Why?
|
| Breast Feeding | 1 | 2024 | 240 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 159 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 855 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2022 | 3422 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2023 | 150 | 0.050 |
Why?
|
| Hepatitis B virus | 1 | 2022 | 142 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 2851 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2022 | 492 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 205 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 431 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 558 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2021 | 309 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2023 | 13020 | 0.040 |
Why?
|
| Equivalence Trials as Topic | 1 | 2018 | 25 | 0.040 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2020 | 195 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2022 | 375 | 0.040 |
Why?
|
| Child | 3 | 2024 | 25835 | 0.040 |
Why?
|
| Infant | 2 | 2024 | 13198 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2024 | 14862 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 767 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 461 | 0.030 |
Why?
|
| Anxiety | 1 | 2023 | 1002 | 0.030 |
Why?
|
| Genotype | 1 | 2022 | 2706 | 0.030 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2015 | 18 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2020 | 938 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2015 | 49 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2015 | 50 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 102 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 160 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5153 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 36 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 96 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 199 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 2013 | 23 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 1247 | 0.030 |
Why?
|
| Isoflurane | 1 | 2013 | 38 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 516 | 0.030 |
Why?
|
| Propofol | 1 | 2013 | 50 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2665 | 0.030 |
Why?
|
| Morphine | 1 | 2013 | 85 | 0.030 |
Why?
|
| Fentanyl | 1 | 2013 | 56 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 247 | 0.020 |
Why?
|
| Quality of Life | 1 | 2023 | 2152 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3745 | 0.020 |
Why?
|
| Depression | 1 | 2021 | 1351 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 1255 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2013 | 351 | 0.020 |
Why?
|
| Young Adult | 2 | 2018 | 9949 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 2904 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 242 | 0.020 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2012 | 148 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1564 | 0.020 |
Why?
|
| Polysomnography | 1 | 2012 | 155 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1723 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2012 | 229 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 471 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 6250 | 0.020 |
Why?
|
| Sleep | 1 | 2012 | 373 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 917 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 3620 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1975 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11631 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3358 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5405 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 4695 | 0.010 |
Why?
|
| Adolescent | 1 | 2022 | 20560 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 6457 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 6540 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21386 | 0.010 |
Why?
|